1. Pink Sheet
  3. >>North America
  4. >>United States

Rx Cost Containment At CareFirst Driven By Physician Incentives

 
• By Cathy Kelly

Legal changes that allow more data sharing can encourage value-based contracting, Executive VP-Medical Affairs Blum says

The pharmaceutical cost containment strategy for Maryland-based insurer CareFirst BlueCross BlueShield revolves around integrating prescription drug and medical costs and incentivizing physicians to reduce them, Executive VP-Medical Affairs Jonathan Blum explained at a recent forum on “Affordable Medicines and Value-Based Payments,” convened by the Bipartisan Policy Center.

“Our medical management strategy is, part and parcel, very much a pharmaceutical management strategy and we look to integrate the...

More from United States

More from North America

Recent And Upcoming FDA Advisory Committee Meetings

 
• By Sue Sutter

Recent and upcoming US FDA advisory committee meetings and a summary of the topics covered.

US FDA Could Miss User Fee Spending Triggers With House FY 2026 Funding

 
• By Sarah Karlin-Smith and Derrick Gingery

FDA employees are concerned that while the budget authority total proposed for fiscal year 2026 meets the user fee appropriations' triggers, the FDA could have trouble meeting allocation triggers without cuts to non-review work.

PCMA, CVS, Cigna File Lawsuits Over ‘Dangerous’ Arkansas PBM Law

 
• By Tim Casey

The suits are an early test of the Arkansas law banning company ownership of PBMs and pharmacies in the state, as other states consider similar legislation.